G. Grant Welstead, et al. Characterization of Cas9-mediated genome editing in human T cells. Presented at the 18th Annual American Society of Gene & Cell Therapy (ASGCT) Meeting, May 14, 2015.

Jun

7

Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer

Jun

6

Editas Medicine Reports Inducement Grants to New Chief Executive Officer

May

18

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting